Uniphar (LON:UPR) Shares Down 2% – Should You Sell?

Uniphar plc (LON:UPR) shares fell 2% on Wednesday . The stock traded as low as GBX 200 ($2.61) and last traded at GBX 200 ($2.61). 20,595 shares changed hands during mid-day trading, a decline of 43% from the average session volume of 36,139 shares. The stock had previously closed at GBX 204 ($2.66).

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 310 ($4.05) target price on shares of Uniphar in a report on Wednesday, September 4th.

Uniphar Trading Down 2.0 %

The firm has a market cap of £546.04 million, a P/E ratio of 1,428.57 and a beta of 0.75. The business’s 50-day moving average is GBX 221.85 and its two-hundred day moving average is GBX 219.18. The company has a debt-to-equity ratio of 119.43, a current ratio of 0.90 and a quick ratio of 0.60.

Uniphar Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, October 4th. Investors of record on Thursday, September 12th were given a €0.01 ($0.01) dividend. This represents a yield of 0.25%. The ex-dividend date was Thursday, September 12th. Uniphar’s dividend payout ratio (DPR) is currently 1,428.57%.

About Uniphar

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, The Netherlands, and internationally. The company operates through three divisions: Medtech, Pharma, and Supply Chain & Retail. The Medtech division offers outsourced sales; and marketing, distribution, and support services to medical device manufacturers.